Kariem Ezzat

@kariemezzat.bsky.social

Research Scientist, Karolinska Institute Co-Founder & CEO, Neuropep Therapeutics #AfricanScientist https://pubmed.ncbi.nlm.nih.gov/?term=Kariem+Ezzat&sort=date https://theprecipitate.blogspot.com/

Grateful to Matt for hosting me on his podcast. We discuss the problems with the prion hypothesis & gain of toxic function models of neurodegenerative diseases. www.youtube.com/watch?v=REln... Some of the discussed work can be found here: pubs.acs.org/doi/10.1021/... academic.oup.com/brain/articl...

Overturning a Nobel Prize: New Discoveries in Prion Diseases - Saving Sapiens S3E2

YouTube video by Saving Sapiens Podcast - Hosted by Dr. Matt David

youtube.com

This figure, which is the most famous in Alzheimer's disease (AD) research, is misleading. The 1st & most consistent biochemical abnormality in AD is CSF Aβ42 going down, not up. Ignoring the neuropeptidergic roles of soluble monomeric Aβ42 & their loss due to its depletion.. 1/2

Bild

This is our best case yet for the evidence of Aβ42 loss of function in Alzheimer's disease (AD). A neuropeptide is a neuropeptide. Ignoring its functions and the fact of its universal depletion in AD and other dementias is a choice made by the field not a scientific mystery. 1/2

Alberto Espay@albertoespay.bsky.social · 12mo ago

For decades, we have tried to suppress γ-secretase, lower Aβ42 levels, or remove amyloid from the brain. We show that PSEN1 mutations already reduce γ-secretase activity and lower Aβ42. Why restoring Aβ42 is the way forward for #Alzheimers, via @Brain1878 academic.oup.com/brain/articl...

"Trial investigators also observed a reduction in the level of a toxic protein linked to neurodegeneration in the spinal fluid of people who received the therapy." Not true, investigators reported earlier a 40% increase of mHTT in the CSF. (pic. from uniqure.gcs-web.com/news-release...) 1/2

Bild
Nature@nature.com · last yr.

A one-time gene therapy can markedly slow the progression of Huntington’s disease, potentially paving the way for the first ever treatment to alter the course of this rare, inherited brain disorder. go.nature.com/4nu6YMs

A good illustration of how new detection technologies are finding direct evidence of viral involvement in neurodegenerative diseases, something that was difficult before & led to the premature exclusion of viruses from disease etiology & the birth of the prion hyp. 1/3 www.cell.com/cell-reports...

Anti-herpetic tau preserves neurons via the cGAS-STING-TBK1 pathway in Alzheimer’s disease

Hyde et al. found elevated HSV-1 protein expression in Alzheimer’s disease, with phosphorylated tau strongly colocalizing with HSV-1 proteins. They demonstrated that tau phosphorylation responds to HS...

cell.com